We also noticed an increased frequency of IL-17-producing cells in CD3+CD4- T cells that included DN T cells in patients with SLE compared with healthy controls (1.65 ± 1.45% versus 0.87 ± 0.53%; P = 0.016). This evidence concerns the gene CD4 and systemic lupus erythematosus.